Xiangchun Zhang

Dr. Xiangchun Zhang

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 December 2023 in Advanced Materials
Verified
Journal Article
Open access
RYRongxin Yu
Rongxin Yu
HCHongping Chen
Hongping Chen
JHJian He
Jian He
ZZZhichao Zhang
Zhichao Zhang
JZJiajing Zhou
Jiajing Zhou
XZXiangchun Zhang
Xiangchun Zhang
Antibiotic‐resistant bacteria pose a global health threat by causing persistent and recurrent microbial infections. To address this issue, antimicrobial nanoparticles (NPs) with low drug resistance but potent bactericidal effects have been developed. However, many of the developed NPs display poor biosafety and their synthesis often involves complex procedures and the antimicrobial modes of action are unclear. Herein, a simple strategy is reported for designing antimicrobial metal‒phenolic network (am‐MPN) NPs through the one‐step assembly of a seeding agent (diethyldithiocarbamate), natural polyphenols, and metal ions (e.g., Cu2+) in aqueous solution. The Cu2+‐based am‐MPN NPs display lower Cu2+ antimicrobial concentrations (by 10–1000 times) lower than most reported nanomaterials and negligible toxicity across various models, including, cells, blood, zebrafish, and mice. Multiple antimicrobial modes of the NPs have been identified, including bacterial wall disruption, reactive oxygen species production, and quinoprotein formation, with the latter being a distinct pathway identified for the antimicrobial activity of the polyphenol‐based am‐MPN NPs. The NPs exhibit excellent performance against multidrug‐resistant bacteria (e.g., methicillin‐resistant Staphylococcus aureus (MRSA)), efficiently inhibit and destroy bacterial biofilms, and promote the healing of MRSA‐infected skin wounds. This study provides insights on the antimicrobial properties of metal‒phenolic materials and the rational design of antimicrobial metal‒organic materials.

29 January 2021 in Advanced Functional Materials
Verified
Journal Article
Closed access
PDF file
XZXiangchun Zhang
Xiangchun Zhang
ZZZhichao Zhang
Zhichao Zhang
QSQingming Shu
Qingming Shu
CXChao Xu
Chao Xu
QZQinqin Zheng
Qinqin Zheng
CLChengyin Lu
Chengyin Lu

15 November 2024 in Journal of Nanobiotechnology
Verified
Journal Article
Open access
PDF file
YYYang Ye
Yang Ye
QZQinqin Zheng
Qinqin Zheng
ZWZiqi Wang
Ziqi Wang
SWShanshan Wang
Shanshan Wang
ZLZhouyu Lu
Zhouyu Lu
XZXiangchun Zhang
Xiangchun Zhang
Bacterial infections, especially induced by multidrug-resistant pathogens, have become a significant global health concern. In the infected tissues, biofilms not only serve as a source of nutrients but also act as protective barriers that impede antibiotic penetration. Herein, we developed tea polyphenols epigallocatechin gallate (EGCG) Au nanoparticles (E-Au NPs) through direct one-step self-assembly methods by EGCG chelating with Au ions to eradicate antibiotic-resistant bacteria methicillin-resistant Staphylococcus aureus (MRSA) and prevent the formation of biofilm under near-infrared (NIR) irradiation. The outstanding antibacterial effect involved in mild photothermal therapy, reactive oxygen species production, pathogenicity-related genes regulation, and quinoprotein formation that were specific to the polyphenol-based NPs. The excellent antibacterial and anti-inflammatory therapeutic efficacy of E-Au NPs was validated and topically applied in murine MRSA-infected skin wounds and keratitis model in vivo to kill bacteria, reduce the inflammation response and promote wound healing. Furthermore, the ophthalmic and systemic biosafety profiles were thoroughly evaluated while no significant side effects were revealed achieving a balance between high-efficiency antibacterial properties and biocompatibility. This study provides an effective therapeutic agent of metal-phenolic materials for superficial tissue infection with favorable prognosis and potential in clinical translation.


29 July 2025 in ACS Nano
Verified
Journal Article
Closed access
WXWei Xu
Wei Xu
XJXiyu Jia
Xiyu Jia
MYMingchuan Yang
Mingchuan Yang
ZPZiyi Peng
Ziyi Peng
Hong-Ping ChenHong-Ping Chen
Hong-Ping Chen
BWBing Wei
Bing Wei

5 July 2022 in Cell Proliferation
Verified
Journal Article
Open access
XZXiangchun Zhang
Xiangchun Zhang
JHJian He
Jian He
LQLiang Qiao
Liang Qiao
ZWZiqi Wang
Ziqi Wang
QZQinqin Zheng
Qinqin Zheng
XHXulin Hu
Xulin Hu
Objectives: 3D‐printing scaffold with specifically customized and biomimetic structures gained significant recent attention in tissue engineering for the regeneration of damaged bone tissues. However, constructed scaffolds that simultaneously promote bone regeneration and in situ inhibit bacterial proliferation remains a great challenge. This study aimed to design a bone repair scaffold with in situ antibacterial functions.Materials and Methods: Herein, a general strategy is developed by using epigallocatechin‐3‐gallate (EGCG), a major green tea polyphenol, firmly anchored in the nano‐hydroxyapatite (HA) and coating the 3D printed polymerization of caprolactone and lactide (PCLA) scaffold. Then, we evaluated the stability, mechanical properties, water absorption, biocompatibility, and in vitro antibacterial and osteocyte inductive ability of the scaffolds.Results: The coated scaffold exhibit excellent activity in simultaneously stimulating osteogenic differentiation and in situ resisting methicillin‐resistant Staphylococcus aureus colonization in a bone repair environment without antibiotics. Meanwhile, the prepared 3D scaffold has certain mechanical properties (39.3 ± 3.2 MPa), and the applied coating provides the scaffold with remarkable cell adhesion and osteogenic conductivity.Conclusion: This study demonstrates that EGCG self‐assembled HA coating on PCLA surface could effectively enhance the scaffold's water absorption, osteogenic induction, and antibacterial properties in situ. It provides a new strategy to construct superior performance 3D printed scaffold to promote bone tissue regeneration and combat postoperative infection in situ.